Original Literature | Model OverView |
---|---|
Publication
Title
Translational mini-review series on Toll-like receptors: recent advances inunderstanding the role of Toll-like receptors in anti-viral immunity.
Affiliation
School of Biochemistry and Immunology, Trinity College Dublin, Ireland.agbowie@tcd.ie
Abstract
(TLRs) respond to pathogens to initiate the innate immune response and directadaptive immunity, and evidence to date suggests that they have a role in thedetection of viruses. Many viral macromolecules have been shown to activateanti-viral signalling pathways via TLRs, leading to the induction of cytokinesand interferons, while viruses also have means of not only evading detection byTLRs, but also of subverting these receptors for their own purposes. This reviewdiscusses the role of TLRs in the context of other known viral detectionsystems, and examines some of the often surprising results from studies usingmice deficient in TLRs and their adaptors, in an attempt to unravel theparticular contribution of TLRs to anti-viral immunity.
PMID
17223961
|
Entity
IFN-beta
--
G010228
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m93217
10
infinite
0
TRANSFAC | G010228 |
--
NF-kappaB{active}
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m27
10
infinite
0
TRANSPATH | MO000000058 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IRF-5
--
MO000007700
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m979
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007700 |
--
IRF-7
--
MO000007702
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m980
10
infinite
0
TRANSPATH | MO000007702 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
TRIF
--
MO000041125
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m18998
10
infinite
0
TRANSPATH | MO000041125 |
--
MAVS
--
MO000094908
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m68199
10
infinite
0
TRANSPATH | MO000094908 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
csml-variable:Double
m11
0
infinite
0
--
csml-variable:Double
m12
0
infinite
0
--
--
e13
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m13
0
infinite
0
--
--
e14
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m14
0
infinite
0
--
--
e15
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m15
0
infinite
0
--
TLR3:Poly(I:C)
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
Viral Glycoproteins
--
e17
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
Viral Glycoproteins:TLR2
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
TLR9:CpG dinucleotides
--
e20
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m20
0
infinite
0
--
csml-variable:Double
m21
0
infinite
0
--
TLR7:ssRNA
--
e22
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m22
0
infinite
0
--
TLR8:ssRNA
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
mRNA
--
e24
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m24
0
infinite
0
--
protein
--
e25
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m25
0
infinite
0
--
Viral Glycoproteins:TLR2:Mal:MyD88
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
NF-kappaB
--
e27
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m28
10
infinite
0
TRANSPATH | MO000000058 |
--
TLR3:Poly(I:C):TRIF
--
e28
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m29
0
infinite
0
--
IRF-3{active}
--
e29
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m30
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IRF-5{active}
--
e30
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m31
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007700 |
--
IRF-7{active}
--
e31
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m32
10
infinite
0
TRANSPATH | MO000007702 |
--
TLR9:CpG dinucleotides:MyD88
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
IRF-1{active}
--
e33
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m34
10
infinite
0
InterPro | IPR001346 |
TRANSPATH | MO000007685 |
--
TLR7:ssRNA:MyD88
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
csml-variable:Double
m36
0
infinite
0
--
DDX58:ssRNA
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
IFIH1:ssRNA
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
DDX58:ssRNA:MAVS
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
IFIH1:ssRNA:MAVS
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
Serine protease
--
e40
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
protein remnants
--
e41
cso30:c:EntityBiological
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m42
0
infinite
0
--
csml-variable:Double
m43
0
infinite
0
--
CD150
--
e43
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m44
0
infinite
0
--
Cd150
--
e44
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m45
0
infinite
0
--
A52
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m46
0
infinite
0
--
A52:TRAF6:IRAK-2
--
e46
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m47
0
infinite
0
--
F protein
--
e47
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m48
0
infinite
0
--
TLR4:F protein
--
e48
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
TLR4:F protein:MyD88:TIRAP
--
e49
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m63
0
infinite
0
--
Poly(I:C)
--
e5
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
PKR:Poly(I:C)
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
TLR4:F protein:TRIF:TRAM
--
e63
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m64
0
infinite
0
--
A46
--
e64
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
TLR4:F protein:TRIF:TRAM:A46
--
e65
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m66
0
infinite
0
--
TLR4:F protein:MyD88:TIRAP:A46
--
e66
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m67
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m119368*m1055*0.1
nodelay
--
0
PMID: 17223961 The first viral PRR to be proposed was PKR, an intracellular detector of dsRNA and polyinosinic?polycytdylic acid (poly(I:C) (a synthetic dsRNA widely used to mimic viral infection).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c30 : 1
stoichiometry:c29 : 1
m24*0.1
nodelay
--
0
PMID: 17223961 A key function of PKR is to inhibit translation of host cell mRNA under conditions of viral invasion by phosphorylating the translation initiation factor eIF2alpha
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m18*m1572*m6810*0.1
nodelay
--
0
PMID: 17223961 The five TIR adaptors, MyD88, Mal, TRIF, TRAM and SARM, are differentially utiilized by TLRs leading to different signalling specificities, Table3 PMID: 17223961 TRAM is uniquely utilized by TLR4 for both NF-KappaB and IRF3 activation, while Mal has been shown to have a role in NF-KappaB activation for both TLR4 and TLR2.
p12
p12
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
stoichiometry:c182 : 1
stoichiometry:c37 : 1
m26*m28*0.1
nodelay
--
0
PMID: 17223961 The five TIR adaptors, MyD88, Mal, TRIF, TRAM and SARM, are differentially utiilized by TLRs leading to different signalling specificities, Table3 PMID: 17223961 TRAM is uniquely utilized by TLR4 for both NF-KappaB and IRF3 activation, while Mal has been shown to have a role in NF-KappaB activation for both TLR4 and TLR2. PMID: 17223961,12566418,15767367 A52 can interact with both TRAF6 and IRAK2 and inhibit TLR-induced NFKappaB activation, especially for TLR3 , while A46 can interact with human MyD88, Mal, TRIF and TRAM and thus inhibit both TLR-induced NF¦ÊB and IRF activation, although it has less of an effect on TLR3-induced NFKappaB activation than A52
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m16*m18998*0.1
nodelay
--
0
p14
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
stoichiometry:c43 : 1
m29*m977*0.1
nodelay
--
0
PMID: 17223961 The five TIR adaptors, MyD88, Mal, TRIF, TRAM and SARM, are differentially utiilized by TLRs leading to different signalling specificities, Table3 PMID: 17223961,16932750 Importantly, TRIF is also the sole adaptor used by TLR3, leading to activation of IRF3, IRF7 and NFKappaB
p14
p15
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m29*m979*0.1
nodelay
--
0
PMID: 17223961 The five TIR adaptors, MyD88, Mal, TRIF, TRAM and SARM, are differentially utiilized by TLRs leading to different signalling specificities, Table3 PMID: 17223961,16932750 Importantly, TRIF is also the sole adaptor used by TLR3, leading to activation of IRF3, IRF7 and NFKappaB
p14
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m29*m980*0.1
nodelay
--
0
PMID: 17223961 The five TIR adaptors, MyD88, Mal, TRIF, TRAM and SARM, are differentially utiilized by TLRs leading to different signalling specificities, Table3 PMID: 17223961,16932750 Importantly, TRIF is also the sole adaptor used by TLR3, leading to activation of IRF3, IRF7 and NFKappaB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m27*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m30*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m32*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m5*m1055*0.1
nodelay
--
0
PMID: 17223961 The first viral PRR to be proposed was PKR, an intracellular detector of dsRNA and polyinosinic?polycytdylic acid (poly(I:C) (a synthetic dsRNA widely used to mimic viral infection).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m31*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m27*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m27*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m27*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c64 : 1
stoichiometry:c66 : 1
m1572*m20*0.1
nodelay
--
0
PMID: 17223961 Table 3 PMID: 17223961,15665823,16006187 It was shown originally to be essential for signalling to TLR-induced NFKappaB activation, but was also shown subsequently to be required for TLR-induced IRF5 activation, and for TLR7- and TLR9-induced IRF7 activation
p25
p25
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m33*m979*0.1
nodelay
--
0
PMID: 17223961 Table 3
p25
p26
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m33*m980*0.1
nodelay
--
0
PMID: 17223961 Table 3
p25
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c183 : 1
stoichiometry:c75 : 1
m33*m28*0.1
nodelay
--
0
PMID: 17223961 Table 3 PMID: 17223961,12566418,15767367 A52 can interact with both TRAF6 and IRAK2 and inhibit TLR-induced NFKappaB activation, especially for TLR3 , while A46 can interact with human MyD88, Mal, TRIF and TRAM and thus inhibit both TLR-induced NF¦ÊB and IRF activation, although it has less of an effect on TLR3-induced NFKappaB activation than A52
p25
p28
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m33*m970*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m34*0.1
nodelay
--
0
PMID: 17223961,17018642 Most recently it has been shown that in myeloid DCs, TLR9-induced IFN-¦Â, IL-12 and inducible macrophage type nitric oxide synthase (iNOS) is dependent on MyD88-mediated IRF1 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c9 : 1
stoichiometry:c8 : 1
m11*m6524*0.1
nodelay
--
0
PMID: 17223961 A key function of PKR is to inhibit translation of host cell mRNA under conditions of viral invasion by phosphorylating the translation initiation factor eIF2alpha
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m34*0.1
nodelay
--
0
PMID: 17223961,17018642 Most recently it has been shown that in myeloid DCs, TLR9-induced IFN-¦Â, IL-12 and inducible macrophage type nitric oxide synthase (iNOS) is dependent on MyD88-mediated IRF1 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m34*0.1
nodelay
--
0
PMID: 17223961,17018642 Most recently it has been shown that in myeloid DCs, TLR9-induced IFN-¦Â, IL-12 and inducible macrophage type nitric oxide synthase (iNOS) is dependent on MyD88-mediated IRF1 activation
p14
p32
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
stoichiometry:c148 : 1
stoichiometry:c87 : 1
m29*m28*0.1
nodelay
--
0
PMID: 17223961 The five TIR adaptors, MyD88, Mal, TRIF, TRAM and SARM, are differentially utiilized by TLRs leading to different signalling specificities, Table3 PMID: 17223961,16932750 Importantly, TRIF is also the sole adaptor used by TLR3, leading to activation of IRF3, IRF7 and NFKappaB PMID: 17223961,12566418,15767367 A52 can interact with both TRAF6 and IRAK2 and inhibit TLR-induced NFKappaB activation, especially for TLR3 , while A46 can interact with human MyD88, Mal, TRIF and TRAM and thus inhibit both TLR-induced NF¦ÊB and IRF activation, although it has less of an effect on TLR3-induced NFKappaB activation than A52
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m22*m1572*0.1
nodelay
--
0
PMID: 17223961 Table 3 PMID: 17223961,15665823,16006187 It was shown originally to be essential for signalling to TLR-induced NFKappaB activation, but was also shown subsequently to be required for TLR-induced IRF5 activation, and for TLR7- and TLR9-induced IRF7 activation
p25
p34
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
stoichiometry:c93 : 1
m35*m28*0.1
nodelay
--
0
PMID: 17223961 Table 3
p25
p35
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c94 : 1
stoichiometry:c96 : 1
m979*m35*0.1
nodelay
--
0
PMID: 17223961 Table 3
p25
p36
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
stoichiometry:c99 : 1
m35*m980*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m41844*m36*0.1
nodelay
--
0
PMID: 17223961,17038589,17038590 These helicases were thought initially to detect viral dsRNA, although recently RIG-I has been shown to recognize uncapped 5¡ì-triphosphate viral ssRNA
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m36*m76904*0.1
nodelay
--
0
PMID: 17223961,17038589,17038590 These helicases were thought initially to detect viral dsRNA, although recently RIG-I has been shown to recognize uncapped 5¡ì-triphosphate viral ssRNA
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m37*m68199*0.1
nodelay
--
0
PMID: 17223961,16127453,16125763,16153868,16177806 RIG-I and Mda5 each contain two caspase-recruitment domains (CARDs) and signal through the same signalling adaptor molecule, IPS-1[also called mitochondrial anti-viral signalling protein (MAVS)], virus-induced signalling adapter (VISA)and CARD adapter inducing IFN-beta (CARDIF), leading to NFKappaB, IRF3 and IRF7 activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m6*m11*0.1
nodelay
--
0
PMID: 17223961 A key function of PKR is to inhibit translation of host cell mRNA under conditions of viral invasion by phosphorylating the translation initiation factor eIF2alpha
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m38*m68199*0.1
nodelay
--
0
PMID: 17223961,16127453,16125763,16153868,16177806 RIG-I and Mda5 each contain two caspase-recruitment domains (CARDs) and signal through the same signalling adaptor molecule, IPS-1[also called mitochondrial anti-viral signalling protein (MAVS)], virus-induced signalling adapter (VISA)and CARD adapter inducing IFN-beta (CARDIF), leading to NFKappaB, IRF3 and IRF7 activation.
p41
p41
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m39*m28*0.1
nodelay
--
0
PMID: 17223961, 16127453,16125763,16153868,16177806 RIG-I and Mda5 each contain two caspase-recruitment domains (CARDs) and signal through the same signalling adaptor molecule, IPS-1[also called mitochondrial anti-viral signalling protein (MAVS)], virus-induced signalling adapter (VISA)and CARD adapter inducing IFN-beta (CARDIF), leading to NFKappaB, IRF3 and IRF7 activation.
p41
p42
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m39*m977*0.1
nodelay
--
0
PMID: 17223961, 16127453,16125763,16153868,16177806 RIG-I and Mda5 each contain two caspase-recruitment domains (CARDs) and signal through the same signalling adaptor molecule, IPS-1[also called mitochondrial anti-viral signalling protein (MAVS)], virus-induced signalling adapter (VISA)and CARD adapter inducing IFN-beta (CARDIF), leading to NFKappaB, IRF3 and IRF7 activation.
p41
p43
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m39*m980*0.1
nodelay
--
0
PMID: 17223961, 16127453,16125763,16153868,16177806 RIG-I and Mda5 each contain two caspase-recruitment domains (CARDs) and signal through the same signalling adaptor molecule, IPS-1[also called mitochondrial anti-viral signalling protein (MAVS)], virus-induced signalling adapter (VISA)and CARD adapter inducing IFN-beta (CARDIF), leading to NFKappaB, IRF3 and IRF7 activation.
p41
p44
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
stoichiometry:c123 : 1
m40*m28*0.1
nodelay
--
0
PMID: 17223961, 16127453,16125763,16153868,16177806 RIG-I and Mda5 each contain two caspase-recruitment domains (CARDs) and signal through the same signalling adaptor molecule, IPS-1[also called mitochondrial anti-viral signalling protein (MAVS)], virus-induced signalling adapter (VISA)and CARD adapter inducing IFN-beta (CARDIF), leading to NFKappaB, IRF3 and IRF7 activation.
p41
p45
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m40*m977*0.1
nodelay
--
0
PMID: 17223961, 16127453,16125763,16153868,16177806 RIG-I and Mda5 each contain two caspase-recruitment domains (CARDs) and signal through the same signalling adaptor molecule, IPS-1[also called mitochondrial anti-viral signalling protein (MAVS)], virus-induced signalling adapter (VISA)and CARD adapter inducing IFN-beta (CARDIF), leading to NFKappaB, IRF3 and IRF7 activation.
p41
p46
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
stoichiometry:c129 : 1
m40*m980*0.1
nodelay
--
0
PMID: 17223961, 16127453,16125763,16153868,16177806 RIG-I and Mda5 each contain two caspase-recruitment domains (CARDs) and signal through the same signalling adaptor molecule, IPS-1[also called mitochondrial anti-viral signalling protein (MAVS)], virus-induced signalling adapter (VISA)and CARD adapter inducing IFN-beta (CARDIF), leading to NFKappaB, IRF3 and IRF7 activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m41*m18998*0.1
nodelay
--
0
PMID: 17223961,15710891 This virus has a serine protease which can cleave TRIF and thus prevent TLR3 signalling to NFKappaB and IRF3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c134 : 1
stoichiometry:c135 : 1
m41*m68199*0.1
nodelay
--
0
PMID: 17223961,15710891 This virus has a serine protease which can cleave TRIF and thus prevent TLR3 signalling to NFKappaB and IRF3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c138 : 1
stoichiometry:c137 : 1
m26*m43*0.1
nodelay
--
0
PMID: 17223961,12163593 For example, the haemagglutinin (HA) protein of wild-type, but not vaccine, strains of measles virus activates murine and human cells via TLR2, leading to induction of proinflammatory cytokines such as IL-6 in human monocytic cells, and up-regulation of surface expression of CD150, the receptor for measles virus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m5*m3965*0.1
nodelay
--
0
PMID: 17223961,15961631,16043704 Although there is still no direct evidence of viral dsRNA binding to TLR3, both Choe et al. and Bell et al. showed that synthetic dsRNA [including poly(I:C)] could indeed bind to the ectodomain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c140 : 1
stoichiometry:c141 : 1
m43*m26*0.1
nodelay
--
0
PMID: 17223961,12163593 For example, the haemagglutinin (HA) protein of wild-type, but not vaccine, strains of measles virus activates murine and human cells via TLR2, leading to induction of proinflammatory cytokines such as IL-6 in human monocytic cells, and up-regulation of surface expression of CD150, the receptor for measles virus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c143 : 1
m44*0.1
nodelay
--
0
PMID: 17223961,12163593 For example, the haemagglutinin (HA) protein of wild-type, but not vaccine, strains of measles virus activates murine and human cells via TLR2, leading to induction of proinflammatory cytokines such as IL-6 in human monocytic cells, and up-regulation of surface expression of CD150, the receptor for measles virus
p52
p52
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c145 : 1
stoichiometry:c146 : 1
stoichiometry:c147 : 1
m1569*m183*m46*0.1
nodelay
--
0
PMID: 17223961,12566418,15767367 A52 can interact with both TRAF6 and IRAK2 and inhibit TLR-induced NFKappaB activation, especially for TLR3 , while A46 can interact with human MyD88, Mal, TRIF and TRAM and thus inhibit both TLR-induced NF¦ÊB and IRF activation, although it has less of an effect on TLR3-induced NFKappaB activation than A52
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c150 : 1
stoichiometry:c151 : 1
m48*m3961*0.1
nodelay
--
0
PMID: 17223961,11062499 The first indication that viral proteins could activate TLRs was the case of the fusion (F) protein of respiratory syncitial virus (RSV)and TLR4
p11
p54
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c153 : 1
stoichiometry:c154 : 1
stoichiometry:c155 : 1
m1572*m6810*m49*0.1
nodelay
--
0
PMID: 17223961 The five TIR adaptors, MyD88, Mal, TRIF, TRAM and SARM, are differentially utiilized by TLRs leading to different signalling specificities, Table3 PMID: 17223961 TRAM is uniquely utilized by TLR4 for both NF-KappaB and IRF3 activation, while Mal has been shown to have a role in NF-KappaB activation for both TLR4 and TLR2.
p11
p55
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c157 : 1
stoichiometry:c158 : 1
stoichiometry:c159 : 1
m19005*m18998*m49*0.1
nodelay
--
0
PMID: 17223961 The five TIR adaptors, MyD88, Mal, TRIF, TRAM and SARM, are differentially utiilized by TLRs leading to different signalling specificities, Table3 PMID: 17223961 TRAM is uniquely utilized by TLR4 for both NF-KappaB and IRF3 activation, while Mal has been shown to have a role in NF-KappaB activation for both TLR4 and TLR2.
p56
p56
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c161 : 1
stoichiometry:c162 : 1
m64*m28*0.1
nodelay
--
0
PMID: 17223961 Table 3
p56
p57
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c164 : 1
stoichiometry:c165 : 1
m63*m28*0.1
nodelay
--
0
PMID: 17223961 Table 3
p56
p58
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c167 : 1
stoichiometry:c168 : 1
m63*m979*0.1
nodelay
--
0
PMID: 17223961 Table 3
p56
p59
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c170 : 1
stoichiometry:c171 : 1
m64*m977*0.1
nodelay
--
0
PMID: 17223961 Table 3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m17*m3964*0.1
nodelay
--
0
PMID: 17223961 Similarly, TLR2 has been shown to mediate cellular responses to viral glycoproteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c172 : 1
stoichiometry:c173 : 1
stoichiometry:c174 : 1
m64*m65*0.1
nodelay
--
0
PMID: 17223961, 12566418, 15767367 A52 can interact with both TRAF6 and IRAK2 and inhibit TLR-induced NFKappaB activation, especially for TLR3 , while A46 can interact with human MyD88, Mal, TRIF and TRAM and thus inhibit both TLR-induced NF¦ÊB and IRF activation, although it has less of an effect on TLR3-induced NFKappaB activation than A52
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c177 : 1
stoichiometry:c178 : 1
stoichiometry:c179 : 1
m65*m63*0.1
nodelay
--
0
PMID: 17223961, 12566418, 15767367 A52 can interact with both TRAF6 and IRAK2 and inhibit TLR-induced NFKappaB activation, especially for TLR3 , while A46 can interact with human MyD88, Mal, TRIF and TRAM and thus inhibit both TLR-induced NF¦ÊB and IRF activation, although it has less of an effect on TLR3-induced NFKappaB activation than A52
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m19828*m19*0.1
nodelay
--
0
PMID: 17223961,11130078 TLR9 was shown originally to be activated by bacterial DNA sequences containing unmethylated CpG dinucleotides
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m19940*m21*0.1
nodelay
--
0
PMID: 17223961 TLR7 and TLR8, which are related more closely to TLR9 than to other TLRs in terms of sequence similarity, also act in endosomes where they have been shown to trigger gene induction in response to viral ssRNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m19823*m21*0.1
nodelay
--
0
PMID: 17223961 TLR7 and TLR8, which are related more closely to TLR9 than to other TLRs in terms of sequence similarity, also act in endosomes where they have been shown to trigger gene induction in response to viral ssRNA.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--